Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Cns Pharmaceuticals (CNSP)

Annual Return

Over the past 3 years, CNSP has had an average annual return of -98.82%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, CNSP has had an average annual return of -93.08%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Nov 8, 2019, CNSP has had an average annual return of -85.74%, underperforming the benchmark SPY, which returned +16.22% annual.

202420232022202120202019
-98.92%-46.86%-88.61%-60.54%-54.93%-13.57%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2024-80.65%+11.11%+30%-42.31%+6.67%-87.50%-50.00%-98.92%
2023-8.00%-16.15%-45.93%+50.68%+21.82%+21.64%+1.23%-24.24%-33.60%+81.93%+0.66%-38.82%-46.86%
2022-14.44%-35.13%-12.54%-0.80%-10.41%-7.54%-21.53%+11.23%-26.73%-10.71%-36.86%-20.81%-88.61%
2021-3.36%+52.90%-9.12%-16.33%-7.50%+5.95%-12.24%-1.17%-12.37%-7.36%-18.84%-37.29%-60.54%
2020+9.12%-13.69%-43.55%+36.67%-7.31%-19.55%-13.09%+15.60%-18.15%-4.44%+33.21%-20.54%-54.93%
2019-9.63%-4.36%-13.57%

Drawdown analysis of Cns Pharmaceuticals (CNSP)

The maximum drawdown for the CNSP was -99.99%, occurring on Jul 30, 2024. This drawdown has not yet recovered.

The current CNSP drawdown is -99.99%.

Since Nov 8, 2019 CNSP has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Jan 10, 20201144Jul 30, 2024OngoingOngoingOngoing
-18.38%Nov 8, 201929Dec 20, 201913Jan 10, 202042